Lindsey Rolfe files SEC Form 4 disclosures for Clovis Oncology, Inc.. They have made 37 open-market trades across 1 company since 2015, most recently 2022-11-02.
CIK 0001650504
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 37 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CLVS | 111,419 | $9K |
Shares reported on the most recent Form 4, priced at the 2022-11-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLVS | SELL | 2022-11-02 | 2022-11-03 | $0.98 | $4K | -62.2% | -69.9% | N/A |
| CLVS | SELL | 2022-09-02 | 2022-09-06 | $1.20 | $3K | +14.5% | +11.8% | -73.5% |
| CLVS | SELL | 2022-08-02 | 2022-08-03 | $1.46 | $6K | -17.5% | -36.2% | -43.5% |
| CLVS | SELL | 2022-06-02 | 2022-06-03 | $0.64 | $2K | +28.0% | +219.0% | +56.2% |
| CLVS | SELL | 2022-05-02 | 2022-05-03 | $1.97 | $8K | -53.8% | -61.1% | -10.7% |
| CLVS | SELL | 2022-03-02 | 2022-03-03 | $1.87 | $20K | -12.3% | +66.9% | -58.7% |
| CLVS | SELL | 2022-02-02 | 2022-02-03 | $1.94 | $9K | +14.3% | -14.3% | -4.0% |
| CLVS | SELL | 2021-12-02 | 2021-12-03 | $3.00 | $1K | +2.5% | +13.4% | -40.8% |
| CLVS | SELL | 2021-11-02 | 2021-11-03 | $4.55 | $19K | -16.7% | -40.8% | -55.2% |
| CLVS | SELL | 2021-09-02 | 2021-09-03 | $4.89 | $2K | -1.1% | -8.2% | -33.3% |
| CLVS | SELL | 2021-08-03 | 2021-08-03 | $4.82 | $20K | +2.6% | +5.2% | -2.1% |
| CLVS | SELL | 2021-06-03 | 2021-06-03 | $5.63 | $2K | +7.9% | +4.5% | -8.0% |
| CLVS | SELL | 2021-05-04 | 2021-05-04 | $5.54 | $25K | +11.2% | +1.7% | -6.8% |
| CLVS | SELL | 2021-03-02 | 2021-03-03 | $6.29 | $4K | +4.4% | +25.2% | -8.9% |
| CLVS | SELL | 2021-02-02 | 2021-02-03 | $7.97 | $172K | -13.2% | -32.4% | -33.2% |
| CLVS | SELL | 2020-12-21 | 2020-12-23 | $5.68 | $10K | -2.9% | +34.1% | +35.5% |
| CLVS | SELL | 2020-12-03 | 2020-12-07 | $4.89 | $3K | +1.2% | -5.0% | +6.5% |
| CLVS | SELL | 2020-11-03 | 2020-11-05 | $4.93 | $9K | -2.4% | +13.8% | +81.3% |
| CLVS | SELL | 2020-09-21 | 2020-09-23 | $6.85 | $12K | -1.7% | -4.6% | -14.2% |
| CLVS | SELL | 2020-09-03 | 2020-09-08 | $5.30 | $3K | +32.7% | +11.3% | -2.5% |
| CLVS | SELL | 2020-08-03 | 2020-08-05 | $5.92 | $11K | -10.2% | -20.2% | -20.3% |
| CLVS | SELL | 2020-06-22 | 2020-06-23 | $6.74 | $12K | -11.6% | -11.2% | -4.2% |
| CLVS | SELL | 2020-06-03 | 2020-06-05 | $7.03 | $5K | +2.3% | -4.2% | -25.5% |
| CLVS | SELL | 2020-05-05 | 2020-05-07 | $8.10 | $14K | -13.9% | -14.7% | -25.9% |
| CLVS | SELL | 2020-03-20 | 2020-03-23 | $4.60 | $8K | +33.1% | +101.1% | +59.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.